The United States FDA has granted orphan drug status to Israeli biotech BioLineRX’s BL-8040 treatment of acute myeloid leukemia. Because there are limited alternatives, BioLineRX will now receive US Federal support, financial assistance and market exclusivity.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000878182&fid=1725
USA promotes Israeli leukemia treatment
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.